Product
description
Subscription to La Merie’s
proprietary Oncology Pipeline Database provides online access to more than
3,000 project entries in oncology. Each project is specified for its Target or
Mechanism of Action, Product Category and R&D Phase. Use of the R&D database
of cancer drugs is intuitive. Data sets of interest can be printed and
exported. Projects are being updated continuously. The R&D history of each
project with online references of information sources can be viewed and
printed. Sales figures of major products are provided. The projects can be
segmented into Territories, Product Categories and R&D Phases. An advanced
search function allows to combine search parameters. A scroll down menu for
predefined targets conveniently selects projects of interest. By clicking on
column heads of the project list, projects can be arranged in ascending or
descending alphabetical or numerical order, e.g. for phase, product category or
company name.
Purchase of the subscription
provides a 1-year online access to the data of the Oncology Database.
Credentials to access the database will be sent by e-mail within 24 hours after
purchase.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/oncology-pipeline-database-1-year-subscription
Benefits
from the Oncology Pipeline Database:
- New database with no historical burden
- Intuitive use
- Designed for structured searches
- Focused on targets, product categories and R&D phases
- Ideal for competitor analysis (companies, targets, product categories)
- Cost-effective and rapid solution for benchmarking
- Identification of licensing candidates
Project
listing in a tabular format:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Product Category
- Company
- Territory
- Therapeutic Area
- Indication
- R&D Phase
Product
Categories:
- Antibodies
- Cells
- DNA
- Medical Devicer / Biomaterial
- Peptide
- Protein
- Radiopharmaceutical
- RNA
- Small Molecule
- Vaccine
Predefined
Targets of the Scroll Down Menu:
- Antibody-Drug Conjugates (ADC)
- Aurora Kinase Inhibitors
- Bcr-Abl and Src Kinase Inhibitors
- c-MET/HGF Inhibitors
- CD3 Antagonists
- CD19 Antagonists
- CD20 Antibodies
- CD22 Antibodies
- CD30 Antibodies
- CD40/L
- CEA Antibodies
- CHK and KSP/Eg5 Inhibitors
- CXCR and CXCL Agonists & Antagonists
- Death Receptors TRAIL-R1/2
- EGF-R Agonists and Antagonists
- EpCAM Antagonists
- G-CSF and GM-CSF
- HDAC Inhibitors
- Heat shock protein 90 (Hsp90) Inhibitors
- Hypoxia-Inducible Factor (HIF)
- IGF-1R Antagonists
- Immunocytokines
- Immunotoxins
- Integrin Antagonists
- Interferon
- Janus Kinase (JAK) Inhibitors
- MEK Inhibitors
- Novel Mitotic Kinase Inhibitors
- PARP Inhibitors
- PDGF-R Agonists and Antagonists
- PI3K-AKT-mTOR Inhibitors
- Polo-like Kinase 1 (Plk-1) Inhibitors
- Proteasome Inhibitors
- Raf Inhibitors
- Ras-Raf-MEK-ERK Inhibitors
- Selective Estrogen Receptor Modulators (SERM)
- TGF-R Agonists and Antagonists
- Thrombopoiesis Stimulating Agents (TPO)
- Toll-Like Receptor (TLR) Agonists and Antagonists
- TRAIL-R1/R2 (Death Receptors)
- VEGF and VEGF-R Agonists and Antagonists
To
Buy The Copy of This Report Visit:
http://www.marketresearchreports.biz/analysis/139850
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are
especially designed to save time and money of our clients. We are a one stop
solution for all your research needs, our main offerings are syndicated
research reports, custom research, subscription access and consulting services.
We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment